RecruitingNot applicableNCT04779593
Impact of Transferrin Saturation Guided Maintenance Treatment on Quality of Life in HFE Haemochromatosis
Studying Symptomatic form of HFE-related hemochromatosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Rennes University Hospital
- Intervention
- Clinical examination(other)
- Enrollment
- 240 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2027
Study locations (12)
- Hopital Avicenne, Bobigny, France
- CHU Dupuytren, Limoges, France
- GHBS site du Scorff, Lorient, France
- GHRMSA - Hôpital Emile Muller, Mulhouse, France
- CHR Orléans, Orléans, France
- Hôpital Européen Georges Pompidou, Paris, France
- CHU Rennes, Rennes, France
- CH Yves le Foll, Saint-Brieuc, France
- CH de St Malo, St-Malo, France
- Hôpital Rangueil, Toulouse, France
- Centre hospitalier Bretagne Atlantique, Vannes, France
- Hôpital Paul Brousse, Villejuif, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04779593 on ClinicalTrials.gov